Individual outcomes are not guaranteed and depend on clinical eligibility, biology, and lifestyle factors
Brayden DJ, Gleeson J, Walsh EG
But tirzepatide appears to offer joint benefits beyond what simple weight reduction would predict
Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in alzheimers disease
For participants receiving 40 mg daily of oral semaglutide, three different dose-titration protocols were used where patients were titrated up to the full 40 mg dose in 6 weeks (fast dose escalation), 12 weeks (standard dose escalation), or 24 weeks (slow dose escalation)
To date, no study has evaluated the clinical effects of these two classes of drugs during the in-hospital phase of AMI